Nasdaq Innovation

A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBHZimmer Biomet (NYSE:ZBH) raised its 2026 sales growth and adjusted earnings outlook after third-quarter growth in hips, surgical specialties and technology offset continued weakness in its knee business. The orthoped

5 Stocks Showing Why Pricing Power Matters More Than Government MoneyShoulder Innovations (NYSE:SI) raised its full-year revenue outlook after reporting 38% growth in the third quarter, as new surgeon additions and higher use of its implants by existing customers helped offset se

MarketBeat Week in Review – 06/22 - 06/26Sweetgreen (NYSE:SG) reported higher third-quarter revenue despite a decline in comparable sales, as executives said customer traffic recovered through the quarter and continued to improve in October. Revenue rose approximately 2% to $176

High Yield Revival: 3 Cash-Rich Dividend Payers on SalePerrigo (NYSE:PRGO) reported lower third-quarter sales and earnings as cautious retailer inventory decisions and weakness in Europe weighed on results, even as the self-care company gained market share and narrowed its core s

Industrial Tech Crossovers: When Manufacturing Meets InnovationITT (NYSE:ITT) raised its full-year earnings and cash flow outlook after third-quarter revenue rose 44%, helped by its acquisition of SPX FLOW and organic growth across all three business segments. The company report

Small Caps Are Crushing the S&P 500—3 Stocks Still Worth BuyingWilldan Group (NASDAQ:WLDN) raised its 2026 financial targets after reporting double-digit revenue growth in the third quarter and closing its acquisition of energy management provider Mantis Innovation. The company a

The Top 3 Medical Devices Stocks to Buy NowBio-Rad Laboratories (NYSE:BIO) reported modest third-quarter revenue growth, its first currency-neutral increase of 2026, as gains in clinical diagnostics and digital PCR instruments helped offset weakness in parts of its life sciences

3 Stocks That Wall Street Insiders Can’t Stop BuyingOPKO Health (NASDAQ:OPK) reported 16% growth in third-quarter revenue from continuing operations and outlined plans to focus on drug development and pharmaceutical products following its proposed sale of BioReference assets to L

Seize the Growth: Twilio’s AI Innovations Are Driving Huge Upside8X8 (NASDAQ:EGHT) raised its fiscal 2027 revenue, earnings and operating cash flow outlook after reporting a sixth consecutive quarter of year-over-year revenue growth, driven in part by demand for usage-based commu

LivaNova (NASDAQ:LIVN) reported third-quarter 2026 revenue growth of 10% from the prior-year period, driven by double-digit gains in its Cardiopulmonary and epilepsy businesses. The medical technology company raised its full-year revenue and adjusted earnings outlook, citing comm

Wall Street Is Betting These 3 Beaten-Down Stocks Have More Room to RunEstee Lauder Companies (NYSE:EL) used its Capital Markets Experience in Shanghai to outline a fiscal 2030 growth and margin plan, citing improving sales momentum, share gains in China, and expanded use of arti

Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow ItBioCryst Pharmaceuticals (NASDAQ:BCRX) reported third-quarter results marked by growth in ORLADEYO revenue, higher profitability and progress across its hereditary angioedema, or HAE, portfolio, while mai

Hospital Stocks - Best Hospital Stocks to BuyFresenius Medical Care AG & Co. KGaA (NYSE:FMS) reported broadly stable third-quarter revenue and a decline in operating income as reimbursement pressures and inflation weighed on results, while the company continued to advance its U.S

Fortune Brands Innovations (NYSE:FBIN) reported third-quarter results that were pressured by softer new-construction demand, service challenges and margin compression, while outlining a multiyear “Back to Business” plan intended to improve execution, simplify its portfolio and ex

These Insider Trades Look Like Clear Signals—Until You Read the Fine PrintCoupang (NYSE:CPNG) reported third-quarter 2026 revenue growth that exceeded its prior outlook in constant-currency terms, while management said its Product Commerce business remains on track to recover mar

Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?California Resources (NYSE:CRC) reported third-quarter 2026 production, cash flow and adjusted EBITDAX above its expectations, while outlining plans to expand its California-focused infrastructure, power and carbon-manage

Graphic Packaging (NYSE:GPK) reported modest year-over-year sales growth and improved sequential profitability in the third quarter of 2026, as cost reductions, productivity initiatives and commercial actions helped offset elevated input-cost inflation and higher maintenance expe

Wall Street's appetite for ETFs shows no signs of slowing. With less than two months left in 2026, new fund launches have already eclipsed last year's record. According to ETF Tracker, 1,159 ETFs had launched through Oct. 20, surpassing the 1,143 introduced in all of 2025. The

Sportradar Rides the Sports Betting Trend From Behind the CurtainSportradar Group (NASDAQ:SRAD) reported third-quarter revenue growth of 24% as demand increased for betting content, streaming, data products and services tied to prediction markets. The company said its integration

Consumer Staples Are Up 12% This Year—These 3 Beverage Stocks Are Leading the WayKeurig Dr Pepper (NASDAQ:KDP) reported third-quarter results marked by substantial sales growth from its JDE Peet’s acquisition, continued double-digit growth in U.S. Refreshment Beverages and improv